Results 211 to 220 of about 4,881,215 (246)
Some of the next articles are maybe not open access.

Alzheimer's Disease

New England Journal of Medicine, 2010
Evidence-based, peer reviewed, best practice management guidelines for neurologists Diagnosis is only part of the puzzle. Effective treatment is what your patients really want. The European Federation of Neurological Societies has been publishing management guidelines in the European Journal of Neurology for many years.
Frank Laferla
exaly   +8 more sources

Alzheimer's disease

Nature Reviews Disease Primers, 2015
Alzheimer's disease is a chronic illness with long preclinical and prodromal phases (20 years) and an average clinical duration of 8-10 years. The disease has an estimated prevalence of 10-30% in the population >65 years of age with an incidence of 1-3%.
Jeffrey Cummings   +2 more
exaly   +5 more sources

Alzheimer's Disease

New England Journal of Medicine, 1986
Robert Katzman, R Katzman
exaly   +3 more sources

Alzheimer's Disease

New England Journal of Medicine, 2004
Jeffrey Cummings
exaly   +3 more sources

Alzheimer's disease

Journal of Internal Medicine, 1992
Alzheimer's disease is one of the most severe and most common chronic diseases of older persons. Because occurrence of the disease is strongly related to age, its public health impact is likely to continue to increase as the population ages. As with many other diseases, a diagnosis of Alzheimer's disease is made through a combination of clinical ...
G. G. GLENNER, Robert A. Kyle
  +7 more sources

Alzheimer's Disease

Annual Review of Medicine, 1985
Significant progress has been made in identifying changes in cholinergic, monoaminergic, and peptidergic neurotransmitter systems in the brains of individuals with Alzheimer's disease. Moreover, neurobiological approaches are beginning to reveal the relationships between these neurotransmitter abnormalities and histological hallmarks of the disease, i ...
D L, Price   +2 more
  +7 more sources

Alzheimer disease

Clinics in Geriatric Medicine, 2018
Alzheimer disease neuropathology is characterized by the extracellular accumulation of Aβ peptide and intracellular aggregation of hyperphosphorylated tau. With the progression of the disease, macroscopic atrophy affects the entorhinal area and hippocampus, amygdala, and associative regions of the neocortex. The locus coeruleus is depigmented.
Ana Laura, Calderon-Garcidueñas   +1 more
openaire   +4 more sources

Alzheimer's disease

The Lancet, 2006
Alzheimer's disease is the most common cause of dementia. Research advances have enabled detailed understanding of the molecular pathogenesis of the hallmarks of the disease--ie, plaques, composed of amyloid beta (Abeta), and tangles, composed of hyperphosphorylated tau.
Kaj, Blennow   +2 more
openaire   +2 more sources

Alzheimer’s disease

Maturitas, 1999
This article reviews the clinical and neuropathological features of Alzheimer's disease, its known genetic and non-genetic risk factors, procedures used to make the diagnosis and rule out other reversible and non-reversible forms of dementia, and the treatment strategies used to help patients and their families cope with the problem.
E M, Reiman, R J, Caselli
openaire   +2 more sources

Alzheimer's disease

British Dental Journal, 1990
Alzheimer's disease (AD) is a debilitating and progressive disease that can affect dental practice in a number of ways. Not only will increasing numbers of AD patients be treated by dentists in the future but the dentist and members of his family may also be unfortunate enough to become affected. In the United Kingdom, nearly 10% of the population over
G H, Moody, J R, Drummond, J P, Newton
openaire   +2 more sources

Home - About - Disclaimer - Privacy